Management of hormone replacement therapy. The Italian experience

被引:5
|
作者
Crosignani, PG
机构
[1] I Clinica Ostetrica e Ginecologica, Università degli Studi, Milan
关键词
hormone replacement therapy; Italy; osteoporosis;
D O I
10.1016/0301-2115(95)02350-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To review the characteristics of users and prescribers of hormone replacement therapy (HRT) in Italy, to attempt to explain the low uptake of this therapy. Methods: A review of the published literature and prescription data. Results: As in many other Western countries, gynaecologists are the main prescribers of HRT in terms of the number of prescriptions/physician/year. However, because general practitioners renew specialists' prescriptions several times a year, they are responsible for the greatest prescription volume. Overall GPs are responsible for 77.6% of HRT prescriptions while gynaecologists account for 20.7%. The attitude of gynaecologists and GPs to HRT is still equivocal and this may be a major factor in the low uptake. The percentage uptake is higher in northern and central Italy than in the south and it has been suggested that women in the hotter southern areas may suffer less from hot flushes. The evidence for this, however, is anecdotal. A recent study in Milan showed that the use of HRT was strongly correlated to social class and level of education. Women with 12 years of education or more were three times more likely to use HRT than those with less than 7 years education. There seemed to be no relationship between marital status and HRT use but fewer parous women used it and use decreased with an increasing number of children. In addition postmenopausal osteoporosis is not yet a registered indication for transdermal HRT, the major route of HRT administration in Italy. Conclusions: An increased uptake is expected in the future due to increased media interest and the greater availability and steady increase of transdermal HRT use over the last 5 years.
引用
收藏
页码:S13 / S15
页数:3
相关论文
共 50 条
  • [1] Menopause and hormone replacement therapy.
    Tellier, P
    Godeau, P
    REVUE DE MEDECINE INTERNE, 2000, 21 (05): : 445 - 457
  • [2] Management of hormone replacement therapy: The Swedish experience
    Mattsson, LA
    Stadberg, E
    Milsom, I
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 64 : S3 - S5
  • [3] Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.
    Hodis H.N.
    Mack W.J.
    Lobo R.
    Current Atherosclerosis Reports, 2002, 4 (1) : 52 - 58
  • [4] Postmenopausal hormone-replacement therapy.
    Manson, JE
    Martin, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01): : 34 - U6
  • [5] Decision analysis of hormone replacement therapy.
    Kim, C
    Kwok, YS
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 302 - 302
  • [6] Atherosclerosis and hormone replacement therapy. Benefit or risk
    Mueck, AO
    GYNAKOLOGE, 2002, 35 (10): : 965 - 974
  • [7] A woman's guide to menopause and hormone replacement therapy.
    Zerbe, KJ
    BULLETIN OF THE MENNINGER CLINIC, 2001, 65 (01) : 126 - 127
  • [8] Physician knowledge and attitudes regarding hormone replacement therapy.
    Wright, JM
    Miller, S
    Rogers, B
    Choksi, H
    PHARMACOTHERAPY, 2003, 23 (03): : 415 - 415
  • [9] Bone mineral density measurement and hormone replacement therapy.
    Rizk, P
    PATHOLOGIE BIOLOGIE, 1998, 46 (05): : 291 - 293
  • [10] A woman's guide to menopause and hormone replacement therapy.
    Kasper, B
    AFFILIA-JOURNAL OF WOMEN AND SOCIAL WORK, 2001, 16 (04): : 515 - 517